EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RETRACTION: Computational and Preclinical Evidence of Anti‐ischemic Properties of L‐Carnitine‐Rich Supplement via Stimulation of Anti‐inflammatory and Antioxidant Events in Testicular Torsed Rats

Oxidative Medicine And Cellular Longevity

Oxidative Medicine and Cellular Longevity · 2026-01 · 2026 (1)

DOI: 10.1155/omcl/9793178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, online erschienen am 10.07.2026. Verfasst von Oxidative Medicine And Cellular Longevity. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cellular Longevity, O. M. A. (2026). RETRACTION: Computational and Preclinical Evidence of Anti‐ischemic Properties of L‐Carnitine‐Rich Supplement via Stimulation of Anti‐inflammatory and Antioxidant Events in Testicular Torsed Rats. Oxidative Medicine and Cellular Longevity, 2026(1). https://doi.org/10.1155/omcl/9793178

Vancouver

Cellular Longevity OMA. RETRACTION: Computational and Preclinical Evidence of Anti‐ischemic Properties of L‐Carnitine‐Rich Supplement via Stimulation of Anti‐inflammatory and Antioxidant Events in Testicular Torsed Rats. Oxidative Medicine and Cellular Longevity. 2026;2026(1). doi:10.1155/omcl/9793178

BibTeX
@article{CellularLongevity2026,
  author = {Cellular Longevity, Oxidative Medicine And},
  title = {RETRACTION: Computational and Preclinical Evidence of Anti‐ischemic Properties of L‐Carnitine‐Rich Supplement via Stimulation of Anti‐inflammatory and Antioxidant Events in Testicular Torsed Rats},
  journal = {Oxidative Medicine and Cellular Longevity},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/omcl/9793178}
}
Kostenlos starten →